Literature DB >> 2414310

Comparison of hormonal secretory behavior of gonadotroph cell adenomas in vivo and in culture.

P J Snyder, H M Bashey, J L Phillips, T A Gennarelli.   

Abstract

To determine whether pituitary macroadenomas associated with supranormal serum FSH concentrations represent gonadotroph cell adenomas or nonsecreting adenomas that selectively impair LH secretion by normal gonadotroph cells, we studied the secretory behavior in dispersed cell culture of three pituitary adenomas from patients who had supranormal serum FSH concentrations. Similar comparisons were made for 11 other adenomas, which were associated with the in vivo hypersecretion of alpha-subunit (n = 4) or PRL/GH (n = 4) or with no obvious hypersecretion (n = 3). Adenomas associated with supranormal serum FSH in vivo released more FSH in culture (5.1-27.0 ng/well . 24 h) than they did other hormones (TSH, less than 0.33; GH, less than 0.10; PRL, less than 0.14 ng/well . 24 h) and more FSH than did PRL/GH-secreting (less than 0.1-0.9 ng/well . 24 h) and nonsecreting (less than or equal to 0.5 ng/well . 24 h) adenomas. Adenomas associated with supranormal serum alpha-subunit in vivo released not only more alpha-subunit in culture (7.2-22.0 ng/well . 24 h) than did other adenomas (0.1-2.4 ng/well . 24 h), but two of them also released as much FSH (12.7 and 17.0 ng/well . 24 h) as did adenomas associated with supranormal serum FSH. The close correlation between the hormonal secretory behavior in vivo and that in culture of the three pituitary macroadenomas associated with supranormal serum FSH concentrations suggests that these are indeed adenomas of gonadotroph cells that are hypersecreting FSH. The release of relatively large amounts of FSH by cultured cells of adenomas that appeared to be hypersecreting only alpha-subunit in vivo suggests that at least some alpha-subunit-secreting adenomas are also gonadotroph cell adenomas.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2414310     DOI: 10.1210/jcem-61-6-1061

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

Review 1.  Receptor imaging in the diagnosis and treatment of pituitary tumors.

Authors:  D J Kwekkeboom; W W de Herder; E P Krenning
Journal:  J Endocrinol Invest       Date:  1999-01       Impact factor: 4.256

2.  Human prolactin-producing pituitary adenomas in three-dimensional culture.

Authors:  J M Guiraud; F Beuron; B Sion; G Brassier; J Faivre; M L Thieulant; J Duval
Journal:  In Vitro Cell Dev Biol       Date:  1991-03

3.  Immunohistochemical studies of human FSH producing pituitary adenomas.

Authors:  R Y Osamura; K Watanabe
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

4.  Predicting the regrowth of clinically non-functioning pituitary adenoma with a statistical model.

Authors:  Sen Cheng; Jiaqi Wu; Chuzhong Li; Yangfang Li; Chunhui Liu; Guilin Li; Wuju Li; Shuofeng Hu; Xiaomin Ying; Yazhuo Zhang
Journal:  J Transl Med       Date:  2019-05-20       Impact factor: 5.531

5.  Integrated analysis of DNA methylation and mRNA expression profiles to identify key genes involved in the regrowth of clinically non-functioning pituitary adenoma.

Authors:  Sen Cheng; Chuzhong Li; Weiyan Xie; Yazhou Miao; Jing Guo; Jichao Wang; Yazhuo Zhang
Journal:  Aging (Albany NY)       Date:  2020-02-03       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.